Artisan Partners
HRTX icon

Artisan Partners’s Heron Therapeutics HRTX Stock Holding History

Artisan Partners’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,343,212
Closed -$28.4M – 367
2020
Q4 		$28.4M Buy
1,343,212
+238,842
+22% +$4.15M 0.03% 285
2020
Q3 		$16.4M Buy
1,104,370
+250,106
+29% +$3.9M 0.02% 290
2020
Q2 		$12.6M Sell
854,264
-275,653
-24% -$4.53M 0.02% 283
2020
Q1 		$13.3M Buy
1,129,917
+69,912
+7% +$1.31M 0.03% 255
2019
Q4 		$24.9M Buy
1,060,005
+410,944
+63% +$9.09M 0.04% 241
2019
Q3 		$12M Buy
649,061
+396,894
+157% +$7.3M 0.02% 255
2019
Q2 		$4.69M Buy
+252,167
New +$5.04M 0.01% 270

Other funds holding HRTX

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Artisan Partners's HRTX Position: Q1 2021 in Review

Artisan Partners sold out of Heron Therapeutics (HRTX) in Q1 2021, closing a stake of 1,343,212 shares — an estimated $28.4M sold.

Artisan Partners first reported a position in HRTX in Q2 2019 and held it in 7 quarters. The position peaked at $28.4M in Q4 2020. 193 funds tracked by Wall St. Rank hold HRTX as of Q1 2021.

  • Artisan Partners reported no remaining Heron Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Artisan Partners sold 1,343,212 Heron Therapeutics shares in Q1 2021, an estimated $28.4M.
  • Artisan Partners first reported a position in Heron Therapeutics in Q2 2019 and held it in 7 quarters.
  • Artisan Partners's Heron Therapeutics position peaked at $28.4M in Q4 2020.
  • 193 funds tracked by Wall St. Rank held Heron Therapeutics as of Q1 2021.

Based on Artisan Partners's 13F filing for Q1 2021, filed 11 May 2021.